BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Cipla Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500087
ISIN Demat
INE059A01026
Book Value (Rs)
411.5600262
NSE Symbol
CIPLA
Divident Yield %
1.17
Market Cap
(Rs In Cr.)
110,790
P/E (TTM)
21.31
EPS (TTM)
64.35
Face Value
(Rs)
2
Date Heading
23-Jan-26 Cipla consolidated net profit declines 56.97% in the December 2025 qua
23-Jan-26 Cipla slides as Q3 PAT tanks 57% YoY to Rs 676 crore
19-Jan-26 Cipla Ltd slips for fifth straight session
07-Jan-26 Cipla Ltd leads losers in 'A' group
24-Dec-25 Cipla declare Quarterly Result
19-Dec-25 Pfizer signs supply and marketing agreement with Cipla
10-Dec-25 Cipla receives ESG rating of 66
13-Nov-25 Cipla Ltd spurts 0.37%, gains for fifth straight session
03-Nov-25 Cipla Ltd - Cipla Limited - Analysts/Institutional Investor Meet/Con.
03-Nov-25 Cipla Ltd - Cipla Limited - Acquisition
31-Oct-25 Cipla slides 5% in two days after management reshuffle; Q2 PAT rises 4
31-Oct-25 Cipla Ltd - Cipla Limited - Copy of Newspaper Publication
30-Oct-25 Cipla consolidated net profit rises 3.73% in the September 2025 quarter
30-Oct-25 Cipla Ltd - Cipla Limited - Press Release
30-Oct-25 Cipla Ltd - Cipla Limited - Change in Director(s)
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)